Avanos Medical, Inc. (AVNS) scores 48 out of 100 on boothcheck's 11-model valuation framework. Verdict: Avoid The estimated fair value is $4.44, representing a 67% premium to fair value. Quantitative score: 60/100. Qualitative score: 30/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.